STATE STREET CORP - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 34 filers reported holding INMUNE BIO INC in Q2 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2023$307,547
-24.7%
44,9630.0%0.00%
Q2 2023$408,264
+40.6%
44,9630.0%0.00%
Q1 2023$290,461
-49.1%
44,963
-50.0%
0.00%
Q4 2022$570,130
+104.3%
89,926
+100.0%
0.00%
Q3 2022$279,000
-29.7%
44,9630.0%0.00%
Q2 2022$397,000
+25.2%
44,963
+19.4%
0.00%
Q1 2022$317,000
-8.1%
37,663
+11.4%
0.00%
Q4 2021$345,000
-35.9%
33,816
+22.0%
0.00%
Q3 2021$538,000
-12.1%
27,716
-20.4%
0.00%
Q2 2021$612,00034,8160.00%
Other shareholders
INMUNE BIO INC shareholders Q2 2023
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 178,284$1,219,4630.13%
Fermata Advisors, LLC 56,702$383,8880.11%
Westside Investment Management, Inc. 41,540$281,2270.08%
QUADRANT CAPITAL GROUP LLC 60,000$406,2000.04%
MAI Capital Management 97,410$659,4660.01%
Janney Montgomery Scott LLC 256,887$1,7390.01%
Financial Advocates Investment Management 11,510$78,3200.01%
VALLEY NATIONAL ADVISERS INC 1,000$70.00%
Beacon Pointe Advisors, LLC 10,368$70,1910.00%
Asset Dedication, LLC 814$60.00%
View complete list of INMUNE BIO INC shareholders